← Back to Treatments
🏅 FDA Orphan Designation

Yuviwel

navepegritide

Manufacturer: Ascendis Pharma Growth Disorders A/S

Indicated for:📚 Achondroplasia

Indications & Usage

to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses

💙 Support Programs

View all →
Yuviwel
Ascendis Pharma Growth Disorders A/S

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.